(Q34582987)

3 August 2017

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity (English)

1 reference

3 August 2017

immunologic cytotoxicity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711560

5 November 2022

1 reference

10.1084/JEM.174.1.139

https://api.crossref.org/works/10.1084/JEM.174.1.139

5 November 2022

2

R S Negrin

1 reference

3 August 2017

I. G. Schmidt-Wolf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711560

5 November 2022

H. P. Kiem

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711560

5 November 2022

K. G. Blume

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711560

5 November 2022

I. L. Weissman

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711560

5 November 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

full work available at URL

3 August 2017

https://europepmc.org/articles/PMC2118875

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711560

https://europepmc.org/articles/PMC2118875?pdf=render

5 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711560

http://rupress.org/jem/article-pdf/174/1/139/1101589/139.pdf

5 November 2022

file format

Portable Document Format

1 reference

Crossref

DOI

10.1084/JEM.174.1.139

https://api.crossref.org/works/10.1084/JEM.174.1.139

Journal of Experimental Medicine

5 November 2022

published in

1 reference

3 August 2017

174

1 reference

3 August 2017

139-149

1 reference

3 August 2017

1

1 reference

A severe combined immunodeficiency mutation in the mouse

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Current understanding of the lymphokine-activated killer cell phenomenon

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

A model of human acute lymphoblastic leukemia in immune-deficient SCID mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Establishment of assays for human hematopoietic cells in immune deficient mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Abelson virus-induced lymphomagenesis in mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

The function of antigen-presenting cells in mice with severe combined immunodeficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118875

Immunoglobulin heavy chain gene diversification in the long-term bone marrow culture of normal mice and mice with severe combined immunodeficiency

27 October 2018

1 reference

12 December 2020

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

1 reference

12 December 2020

Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells

1 reference

12 December 2020

Use of scid mice to identify and quantitate lymphoid-restricted stem cells in long-term bone marrow cultures

1 reference

12 December 2020

The biology of the SCID mutation

1 reference

12 December 2020

Lymphokine-activated killer cell activity after cryopreservation

1 reference

12 December 2020

Growth of human tumors in immune-deficient scid mice and nude mice

1 reference

12 December 2020

Transfer of a functional human immune system to mice with severe combined immunodeficiency

1 reference

12 December 2020

Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells

1 reference

12 December 2020

Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro

1 reference

12 December 2020

Infection of the SCID-hu mouse by HIV-1

1 reference

12 December 2020

Technical aspects of lymphokine-activated killer cell production

1 reference

12 December 2020

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Natural killer cells: definition of a cell type rather than a function

1 reference

12 December 2020

Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency

1 reference

12 December 2020

T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of scid mice

1 reference

12 December 2020

Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid)

1 reference

12 December 2020

Establishment of a human cutaneous T-cell lymphoma in C.B-17 SCID mice

1 reference

12 December 2020

Suppression of HIV infection in AZT-treated SCID-hu mice

1 reference

12 December 2020

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

12 December 2020

Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2

1 reference

12 December 2020

Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.174.1.139

1 reference

3 August 2017

1 reference

3 August 2017

1 reference